Mankind Pharma News and Resources

Mankind Pharma has received approval from the Competition Commission of India (CCI) for the acquisition of Bharat Serums and Vaccines (BSV) for $1.64 billion. The transaction involves acquiring a 100% stake in BSV. This strategic move is seen as a

Mankind Pharma, a prominent player in the Indian OTC drug market, has finalised the acquisition of Bharat Serums and Vaccines (BSV) from global investor Advent International. The deal, valued at Rs 13,630 crore, was announced in a joint statement on